That drug wasn't even the leader in the cholesterol-fighting pack, led by Merck (nyse: MRK - news - people), Pfizer (nyse: PFE - news - people), and Bristol-Myers Squibb (nyse: BMY - news - people).
Those with good cholesterol levels typically don't have their hs-CRP levels tested because there are no clear guidelines on who should be tested and how often.